Header Logo

Pauline Merrill

Concepts (104)

Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.


Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Macular Edema
5
2022
6
2.580
Why?
Uveitis
8
2021
10
2.200
Why?
Uveitis, Posterior
3
2020
3
1.020
Why?
Adalimumab
3
2020
12
1.010
Why?
Sirolimus
3
2020
19
0.970
Why?
Posterior Eye Segment
2
2020
2
0.830
Why?
Diabetic Retinopathy
1
2022
5
0.820
Why?
Diabetes Mellitus
1
2022
127
0.740
Why?
Intravitreal Injections
6
2022
10
0.670
Why?
Rituximab
2
2019
44
0.660
Why?
Immunologic Factors
1
2019
33
0.630
Why?
Rickettsia Infections
1
2016
1
0.520
Why?
Retinitis
1
2016
2
0.510
Why?
Eye Infections, Bacterial
1
2016
9
0.510
Why?
Tomography, Optical Coherence
5
2021
16
0.490
Why?
Glucocorticoids
4
2022
58
0.470
Why?
Visual Acuity
6
2021
38
0.460
Why?
Triamcinolone Acetonide
3
2021
7
0.420
Why?
Adrenal Cortex Hormones
3
2021
101
0.390
Why?
Double-Blind Method
4
2020
411
0.380
Why?
Humans
21
2022
26260
0.360
Why?
Panuveitis
2
2020
2
0.330
Why?
Uveitis, Intermediate
2
2020
2
0.330
Why?
Immunosuppressive Agents
3
2020
130
0.330
Why?
Treatment Outcome
8
2021
3285
0.320
Why?
Female
11
2020
14520
0.280
Why?
Middle Aged
11
2020
8541
0.250
Why?
Dose-Response Relationship, Drug
3
2020
330
0.240
Why?
Time Factors
4
2020
1347
0.220
Why?
Retrospective Studies
6
2022
3283
0.210
Why?
Vision Disorders
2
2019
20
0.210
Why?
Fluocinolone Acetonide
1
2022
1
0.210
Why?
Drug Implants
1
2022
9
0.210
Why?
Aged
8
2020
8595
0.200
Why?
Choroid Diseases
1
2002
2
0.200
Why?
Retinal Diseases
1
2002
4
0.200
Why?
Treatment Failure
2
2020
158
0.200
Why?
Angiostrongylus cantonensis
1
2021
1
0.190
Why?
Strongylida Infections
1
2021
1
0.190
Why?
Retinal Detachment
1
2021
7
0.190
Why?
Male
10
2021
14168
0.190
Why?
Electronic Health Records
2
2019
69
0.190
Why?
Adult
8
2020
7516
0.180
Why?
Follow-Up Studies
3
2020
1722
0.170
Why?
Databases, Factual
2
2019
315
0.170
Why?
Intraocular Pressure
1
2020
8
0.170
Why?
Anti-Inflammatory Agents
2
2020
72
0.170
Why?
Kaplan-Meier Estimate
1
2020
160
0.170
Why?
Uveitis, Anterior
1
2019
3
0.160
Why?
Spondylarthropathies
1
2019
3
0.160
Why?
Proportional Hazards Models
1
2020
321
0.160
Why?
International Classification of Diseases
1
2018
11
0.160
Why?
Academic Medical Centers
1
2019
124
0.150
Why?
Prospective Studies
1
2022
1665
0.140
Why?
Retina
1
2016
7
0.140
Why?
Retinal Necrosis Syndrome, Acute
2
2008
3
0.130
Why?
Chorioretinitis
1
2016
1
0.130
Why?
Rickettsia
1
2016
1
0.130
Why?
Africa
1
2016
9
0.130
Why?
HLA-A Antigens
1
2016
12
0.130
Why?
Travel
1
2016
13
0.130
Why?
Retinal Neoplasms
1
2013
1
0.110
Why?
Antibodies, Monoclonal, Murine-Derived
1
2013
26
0.110
Why?
Lymphoma
1
2013
31
0.110
Why?
Ocular Hypotension
1
2012
1
0.100
Why?
Antineoplastic Agents
1
2013
178
0.100
Why?
Eye Infections, Viral
1
2008
3
0.080
Why?
Drug Resistance, Viral
1
2008
14
0.070
Why?
AIDS-Related Opportunistic Infections
1
2008
39
0.070
Why?
Young Adult
3
2020
1948
0.070
Why?
Animals
3
2021
3551
0.060
Why?
Magnetic Resonance Angiography
1
2004
29
0.060
Why?
Vasculitis, Central Nervous System
1
2004
7
0.060
Why?
Prevalence
2
2019
441
0.060
Why?
Risk Factors
2
2019
2221
0.060
Why?
Aged, 80 and over
3
2020
4594
0.050
Why?
Exudates and Transudates
1
2002
1
0.050
Why?
Remission, Spontaneous
1
2002
9
0.050
Why?
Hawaii
1
2021
3
0.050
Why?
Magnolia
1
2021
1
0.050
Why?
Injections, Subcutaneous
1
2020
25
0.040
Why?
Women's Health
1
2002
151
0.040
Why?
Rats
1
2021
634
0.040
Why?
Delayed Diagnosis
1
2019
10
0.040
Why?
Computer Systems
1
2018
7
0.040
Why?
Drug Evaluation, Preclinical
1
2018
30
0.040
Why?
Adolescent
2
2016
2172
0.040
Why?
Predictive Value of Tests
1
2019
422
0.040
Why?
Clinical Trials as Topic
1
2018
211
0.030
Why?
Sensitivity and Specificity
1
2018
473
0.030
Why?
Prognosis
1
2019
710
0.030
Why?
Chicago
1
2019
857
0.030
Why?
Reproducibility of Results
1
2018
683
0.030
Why?
Disease-Free Survival
1
2016
163
0.030
Why?
Acute Disease
1
2016
190
0.030
Why?
Evidence-Based Medicine
1
2016
169
0.030
Why?
Diagnosis, Differential
1
2016
343
0.030
Why?
Chronic Disease
1
2016
413
0.030
Why?
Severity of Illness Index
1
2012
853
0.020
Why?
Acyclovir
1
2008
4
0.020
Why?
Ganciclovir
1
2008
8
0.020
Why?
Prednisone
1
2008
54
0.020
Why?
Immunocompromised Host
1
2008
43
0.020
Why?
Drug Therapy, Combination
1
2008
169
0.020
Why?
Merrill's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (104)
Explore
_
Co-Authors (5)
Explore
_
Similar People (60)
Explore
_
Same Department Expand Description
Explore
_